Abstract: The present invention relates to Map4K1 inhibitors of formula (I) (I), wherein A, E, G, Q, R1, R2 and R4 have the same meaning as defined in the description, to pharmaceutical compositions and combinations comprising the compounds according to the invention, and to the prophylactic and therapeutic use of the inventive compounds, respectively to the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular for neoplastic disorders, respectively cancer or conditions with dysregulated immune responses or other disorders associated with aberrant MAP4K1 signaling, as a sole agent or in combination with other active ingredients.

Abstract: A reward processing method, system, apparatus, and computer program code is provided. Pursuant to some embodiments, the method includes analyzing transaction data associated with a plurality of payment transactions, each payment transaction including data identifying a payment account identifier, a transaction date, a transaction amount, and a merchant identifier, and identifying a first set of the payment transactions involving registered payment account identifiers. A second set of payment transactions involving a registered merchant identifier and a current offer are identified, and a reward amount earned for each of the second set is calculated. The reward amount is credited to each of the payment account identifiers in the second set.

Abstract: An independently powered slots architecture for use in telecom/datacom systems, the architecture including the capability to support at least one power module, and may include a manager module, a storage module, an alarm module, a console module, and a cooling module. Method for using same also disclosed.